A total of 51 companies in 17 countries have been selected by the European Innovation Council Accelerator, in a competitive process involving 551 candidates. MiMARK Diagnostics and the Madrid-based company, Oils4Cure have been the only Spanish companies to be chosen.

The €2.5 M awarded by the European Innovation Council Accelerator adds to the million euros raised by MiMARK Diagnostics in a funding operation announced a few days ago and led by the Clave Capital, Nara Capital and Namarel Ventures risk capital fund, in which the WA4Steam Business Angels network has also participated.

“The funding from the European Innovation Council Accelerator represents a European seal of excellence which will allow us to accelerate the validation of ourfirst product, WomEC,” celebrates Marina Rigau, CEO and co-founder of MiMARK Diagnostics. WomEC is an in vitro diagnostic test for endometrial cancer based on the analysis of proteins present in uterine fluid.

The European Innovation Council (EIC) Accelerator offers grants of up to €2.5 million over two years to innovative start-up companies and SMEs, combined with capital investments through the EIC fund of between €0.5 million and €15 million or more. In addition to financial support, selected projects benefit from business acceleration services. In this call, the 51 selected companies will receive total funding of €260 M.